Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer-Reference-Cited by-同舟云学术

Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer

Published:2023-08-21 Issue:13 Volume:30 Page:8704-8716
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Shiozaki Atsushi^ORCID,Fukami Tomoyuki,Shimizu Hiroki,Kosuga Toshiyuki,Kudou Michihiro,Takemoto Kenichi,Katsurahara Keita,Nishibeppu Keiji,Ohashi Takuma,Arita Tomohiro,Konishi Hirotaka,Komatsu Shuhei,Kubota Takeshi,Fujiwara Hitoshi,Otsuji Eigo

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-14084-0.pdf

Reference43 articles.

1. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–48.

2. Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Crit Rev Oncol Hematol. 2009;71(2):127–64.

3. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

4. Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–71.

5. Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27–40.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: Effects of TRPV2 on the Expression of PD-L1 and Its Ability to Bind to PD-1 in Gastric Cancer;Annals of Surgical Oncology;2023-08-10